Therefore, we hypothesized that α-Mangostin exerts anti-lung cancer activity and has the advantage of low toxicity to further study its actions and mechanisms against NSCLC harboring EGFR T790M mutation. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.